| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Counted by filing, the last 12 months brought no open-market purchases and 9 sales by 7 insiders worth about $183K. The 12 months before that brought 1 open-market purchase by 1 insider worth about $256K and 6 sales by 6 insiders worth about $127K.
None of the 9 sales in the last 12 months was marked as made under a Rule 10b5-1 trading plan.
The largest open-market purchase in the last two years was 45,000 shares by Jay R. Luly (President and CEO) at an average $5.69 on February 12, 2025, about $256K. Twelve months later ENTA was up 136%.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 871.9K | $9.04M | - | |
| Other | 374.9K | $3.89M | - | |
| Other | 41.6K | $431.7K | - | |
| Other | 33.9K | $351.8K | - | |
| Other | 23.8K | $246.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | Kathleen S. Capps | See Remarks | Sell | 323 | $14.23 | $4,596.29 | -3.7% | -5.8% | - | |
| Dec 5, 2025 | Brendan Luu | Chief Business Officer | Sell | 1,394 | $14.23 | $19,836.62 | -3.5% | -5.8% | - | |
| Dec 5, 2025 | Harry R. Trout III | See Remarks | Sell | 542 | $14.23 | $7,712.66 | -3.2% | -5.8% | - | |
| Dec 5, 2025 | Scott T. Rottinghaus69 | Chief Medical Officer | Sell | 798 | $14.23 | $11,355.54 | -3.5% | -5.8% | - | |
| Dec 5, 2025 | Jay R. Luly71 | President and CEO | Sell | 4,743 | $14.23 | $67,492.89 | -0.5% | -5.8% | - | |
| Dec 5, 2025 | Yat Sun Or59 | Chief Scientific Officer | Sell | 2,390 | $14.23 | $34,009.70 | -0.6% | -5.8% | - | |
| Dec 5, 2025 | Tara Lynn Kieffer54 | Chief Product Strategy Officer | Sell | 2,106 | $14.23 | $29,968.38 | -6.4% | -5.8% | - | |
| Dec 2, 2025 | Kathleen S. Capps | See Remarks | Sell | 207 | $13.96 | $2,889.72 | -2.3% | +3.9% | - | |
| Dec 2, 2025 | Harry R. Trout III | See Remarks | Sell | 380 | $13.96 | $5,304.80 | -2.2% | +3.9% | - | |
| Feb 12, 2025 | Jay R. Luly71 | President and CEO | Buy | 45,000 | $5.69 | $256,050.00 | +5.6% | -10.8% | +136.2% |